Tiina Karonen

Person

Latest publications

  1. SLCO2B1 c.935G > A single nucleotide polymorphism has no effect on the pharmacokinetics of montelukast and aliskiren

    Tapaninen, T., Karonen, T., Backman, J. T., Neuvonen, P. J. & Niemi, M., Jan 2013, In : Pharmacogenetics and Genomics. 23, 1, p. 19-24 6 p.

    Research output: Contribution to journalArticleScientificpeer-review

  2. CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast

    Karonen, T., Neuvonen, P. J. & Backman, J. T., Jan 2012, In : British Journal of Clinical Pharmacology. 73, 2, p. 257-67

    Research output: Contribution to journalArticleScientificpeer-review

  3. Fluconazole but not the CYP3A4 inhibitor, itraconazole, increases zafirlukast plasma concentrations

    Karonen, T., Laitila, J., Niemi, M., Neuvonen, P. J. & Backman, J. T., 2012, In : European Journal of Clinical Pharmacology. 68, 5, p. 681-688 8 p.

    Research output: Contribution to journalArticleScientificpeer-review

View all (7) »

ID: 73582